OBJECTIVES: To obtain timely and detailed data on COVID-19 cases in the United States, the Centers for Disease Control and Prevention (CDC) uses 2 data sources: (1) aggregate counts for daily situational awareness and (2) person-level data for each case (case surveillance). The objective of this study was to describe the sensitivity of case ascertainment and the completeness of person-level data received by CDC through national COVID-19 case surveillance. METHODS: We compared case and death counts from case surveillance data with aggregate counts received by CDC during April 5-September 30, 2020. We analyzed case surveillance data to describe geographic and temporal trends in data completeness for selected variables, including demographic characteristics, underlying medical conditions, and outcomes. RESULTS: As of November 18, 2020, national COVID-19 case surveillance data received by CDC during April 5-September 30, 2020, included 4 990 629 cases and 141 935 deaths, representing 72.7% of the volume of cases (n = 6 863 251) and 71.8% of the volume of deaths (n = 197 756) in aggregate counts. Nationally, completeness in case surveillance records was highest for age (99.9%) and sex (98.8%). Data on race/ethnicity were complete for 56.9% of cases; completeness varied by region. Data completeness for each underlying medical condition assessed was <25% and generally declined during the study period. About half of case records had complete data on hospitalization and death status. CONCLUSIONS: Incompleteness in national COVID-19 case surveillance data might limit their usefulness. Streamlining and automating surveillance processes would decrease reporting burdens on jurisdictions and likely improve completeness of national COVID-19 case surveillance data.
OBJECTIVES: To obtain timely and detailed data on COVID-19 cases in the United States, the Centers for Disease Control and Prevention (CDC) uses 2 data sources: (1) aggregate counts for daily situational awareness and (2) person-level data for each case (case surveillance). The objective of this study was to describe the sensitivity of case ascertainment and the completeness of person-level data received by CDC through national COVID-19 case surveillance. METHODS: We compared case and death counts from case surveillance data with aggregate counts received by CDC during April 5-September 30, 2020. We analyzed case surveillance data to describe geographic and temporal trends in data completeness for selected variables, including demographic characteristics, underlying medical conditions, and outcomes. RESULTS: As of November 18, 2020, national COVID-19 case surveillance data received by CDC during April 5-September 30, 2020, included 4 990 629 cases and 141 935 deaths, representing 72.7% of the volume of cases (n = 6 863 251) and 71.8% of the volume of deaths (n = 197 756) in aggregate counts. Nationally, completeness in case surveillance records was highest for age (99.9%) and sex (98.8%). Data on race/ethnicity were complete for 56.9% of cases; completeness varied by region. Data completeness for each underlying medical condition assessed was <25% and generally declined during the study period. About half of case records had complete data on hospitalization and death status. CONCLUSIONS: Incompleteness in national COVID-19 case surveillance data might limit their usefulness. Streamlining and automating surveillance processes would decrease reporting burdens on jurisdictions and likely improve completeness of national COVID-19 case surveillance data.
Entities:
Keywords:
COVID-19; SARS-CoV-2; case surveillance; data completeness; race/ethnicity
Authors: William R Mac Kenzie; Arthur J Davidson; Andrew Wiesenthal; Jeffrey P Engel; Kathryn Turner; Laura Conn; Scott J Becker; Sharon Moffatt; Samuel L Groseclose; Jim Jellison; John Stinn; Nedra Y Garrett; Lesliann Helmus; Bob Harmon; Chesley L Richards; John R Lumpkin; Michael F Iademarco Journal: Public Health Rep Date: 2016-10-13 Impact factor: 2.792
Authors: Jonathan M Wortham; James T Lee; Sandy Althomsons; Julia Latash; Alexander Davidson; Kevin Guerra; Kenya Murray; Emily McGibbon; Carolina Pichardo; Brian Toro; Lan Li; Marc Paladini; Meredith L Eddy; Kathleen H Reilly; Lisa McHugh; Deepam Thomas; Stella Tsai; Mojisola Ojo; Samantha Rolland; Maya Bhat; Katherine Hutchinson; Jennifer Sabel; Seth Eckel; Jim Collins; Catherine Donovan; Anna Cope; Breanna Kawasaki; Sarah McLafferty; Nisha Alden; Rachel Herlihy; Bree Barbeau; Angela C Dunn; Charles Clark; Pamela Pontones; Meagan L McLafferty; Dean E Sidelinger; Anna Krueger; Leslie Kollmann; Linnea Larson; Stacy Holzbauer; Ruth Lynfield; Ryan Westergaard; Richard Crawford; Lin Zhao; Jonathan M Bressler; Jennifer S Read; John Dunn; Adele Lewis; Gillian Richardson; Julie Hand; Theresa Sokol; Susan H Adkins; Brooke Leitgeb; Talia Pindyck; Taniece Eure; Karen Wong; Deblina Datta; Grace D Appiah; Jessica Brown; Rita Traxler; Emilia H Koumans; Sarah Reagan-Steiner Journal: MMWR Morb Mortal Wkly Rep Date: 2020-07-17 Impact factor: 17.586
Authors: Sarah M Hatcher; Christine Agnew-Brune; Mark Anderson; Laura D Zambrano; Charles E Rose; Melissa A Jim; Amy Baugher; Grace S Liu; Sadhna V Patel; Mary E Evans; Talia Pindyck; Christine L Dubray; Jeanette J Rainey; Jessica Chen; Claire Sadowski; Kathryn Winglee; Ana Penman-Aguilar; Amruta Dixit; Eudora Claw; Carolyn Parshall; Ellen Provost; Aurimar Ayala; German Gonzalez; Jamie Ritchey; Jonathan Davis; Victoria Warren-Mears; Sujata Joshi; Thomas Weiser; Abigail Echo-Hawk; Adrian Dominguez; Amy Poel; Christy Duke; Imani Ransby; Andria Apostolou; Jeffrey McCollum Journal: MMWR Morb Mortal Wkly Rep Date: 2020-08-28 Impact factor: 17.586
Authors: Jazmyn T Moore; Jessica N Ricaldi; Charles E Rose; Jennifer Fuld; Monica Parise; Gloria J Kang; Anne K Driscoll; Tina Norris; Nana Wilson; Gabriel Rainisch; Eduardo Valverde; Vladislav Beresovsky; Christine Agnew Brune; Nadia L Oussayef; Dale A Rose; Laura E Adams; Sindoos Awel; Julie Villanueva; Dana Meaney-Delman; Margaret A Honein Journal: MMWR Morb Mortal Wkly Rep Date: 2020-08-21 Impact factor: 17.586
Authors: Carolyn M Shover; Peter Yan; Nicholas J Jackson; Russell G Buhr; Jennifer A Fulcher; Donald P Tashkin; Igor Barjaktarevic Journal: J Cannabis Res Date: 2022-08-05